Discover 1,933 paid clinical trials in Richardson, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,933
Featured
A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
for
Alzheimer's Disease
Location: Dallas TX, Cordova TN, Boulder CO, Lady Lake FL,
Sponsor: AbbVie
Sex: All
Age: 50 - 70+
Code: NCT07599670
Phase 1, Phase 2, Recruiting
Featured
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
for
Alzheimers Disease
Location: Dallas TX, Fort Worth TX, Katy TX, Houston TX,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 50 - 70+
Code: NCT07177352
Phase 3, Recruiting
Featured
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
for
Non-Small Cell Lung Cancer
Location: Plano TX, Houston TX, San Antonio TX, Westwood KS,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06236438
Phase 2, Phase 3, Recruiting
Featured
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
for
Alopecia Areata
Location: Dallas TX, Arlington TX, Cedar Park TX, Bellaire TX,
Sponsor: AbbVie
Sex: All
Age: 12 - 63
Code: NCT06012240
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Featured
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
for
Parkinson's Disease
Location: Dallas TX, Round Rock TX, Tulsa OK, Memphis TN,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 50 - 70+
Code: NCT07174310
Phase 3, Recruiting
Featured
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
for
Atherosclerosis
Location: Dallas TX, Houston TX, San Antonio TX, St Louis MO,
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT07448038
Phase 2, Recruiting
Featured
Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants Undergoing Open Abdominal Ventral Hernia Repair
for
Ventral Hernia
Location: Dallas TX, Pensacola FL, Rochester MN, Evanston IL,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT07226791
Phase 2, Recruiting
Featured
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy
for
Muscular Atrophy, Spinal
Location: Dallas TX, Fort Worth TX, Little Rock AR, Aurora CO,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 0 - 2
Code: NCT05861986
Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
for
Ovarian Cancer
Location: Dallas TX, Fort Worth TX, Tyler TX, Abilene TX,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT07059845
Phase 2, Recruiting
Featured
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
for
Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer
Location: Dallas TX, Fort Worth TX, Tyler TX, Kingwood TX,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT06793215
Phase 3, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
for
Multiple Myeloma
Location: Dallas TX, Charlotte NC, Ann Arbor MI, Winston-Salem NC,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06953960
Phase 1, Phase 2, Recruiting
Featured
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
for
Ulcerative Colitis
Location: Dallas TX, Atlanta GA, Chicago IL, Greenville SC,
Sponsor: AbbVie
Sex: All
Age: 2 - 17
Code: NCT07071519
Phase 3, Recruiting
Featured
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
for
Non-Small Cell Lung Cancer, c-MET
Location: Dallas TX, Tyler TX, Little Rock AR, Lincoln NE,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06568939
Phase 2, Recruiting
Featured
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
for
Breast Cancer
Location: Dallas TX, St Louis MO, Huntsville AL, Nashville TN,
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT07100106
Phase 1, Phase 2, Recruiting
Featured
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
for
Acute Myeloid Leukemia
Location: Dallas TX, Nashville TN, Atlanta GA, Valhalla NY,
Sponsor: AbbVie
Sex: All
Age: 0 - 17
Code: NCT07306832
Phase 1, Recruiting
Featured
A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous Tumors
for
Advanced Squamous Tumors
Location: Irving TX, Chicago IL, Grand Rapids MI, Huntersville NC,